Should AAPL Invest in Diabetes Treatment

Should AAPL Invest in Diabetes Treatment?

Jim Cramer of TheStreet.com and Real Money author says Apple (AAPL) should invest in diabetes treatment. There’s two companies out there blowing past other device makers, Dexcom and Tandem Diabetes. Dexcom offers the G-6 continuous glucose monitor (CGM) while Tandem offers the t:slim X2 Insulin Pump for diabetes sufferers. The G-6 cgm doesn’t require finger sticks for…

Doug Melton and research assistant Peng Yi at Harvard

Diabetes Breakthrough Announced by Harvard Stem Cell Researchers

Researchers at Harvard University announce a major diabetes breakthrough in finding a treatment and possible cure for type 1 diabetes from human embryonic stem cells. The scientists were able to produce insulin-producing beta cells from stem cells in very large volumes that would be required for cell transplantation as well as pharmaceutical use. Lead researcher…